Intaxel 30 mg Inj

Paclitaxel belongs to a class of chemotherapy medications known as taxanes, which work by stabilizing microtubules within cancer cells, preventing them from breaking down properly during cell division. This disruption traps cancer cells in the process of dividing, ultimately leading to their destruction and helping slow tumor growth. It is commonly used in the treatment of breast cancer, ovarian cancer, and non-small cell lung cancer, often as part of a broader combination chemotherapy regimen alongside other agents. Paclitaxel is also used in certain cases of Kaposi's sarcoma, expanding its role across various cancer types. The medication is administered through intravenous infusion, typically in a hospital or specialized oncology setting, allowing healthcare providers to closely monitor the patient during and after administration. Premedication is often given before infusion to help minimize infusion-related reactions and improve patient comfort. Treatment schedules and dosing are carefully individualized based on the specific type and stage of cancer, as well as the patient's overall health and treatment history. Regular monitoring, including blood counts and nerve function assessments, is an important part of care throughout treatment to help guide safe and effective dosing. Many patients experience meaningful tumor response and improved disease management as part of a comprehensive cancer treatment plan involving Paclitaxel. As with all chemotherapy medications, Paclitaxel injection should be administered under the close supervision of an experienced oncology healthcare team.